Period of time： 2004年1期
Publisher： Elsevier
Founded in： 2002
Total resources： 4
ISSN： 1474-4422
Subject： R74 Neurology and Psychiatry
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Lancet Neurology,volume 3,issue 1
Menu
Access to resources
Recommend
Cocaine use may damage dopaminergic system
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Stroke: prediction, prevention, and outcome
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Multiple sclerosis: disease markers accelerate progress
By Fox R.J., Rudick R.A. in (2004)
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Epilepsy: major advances in treatment
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Important advances in headache
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Neuro-oncology: diagnosis in the spotlight
By Sillevis Smitt P. in (2004)
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Movement disorders: Parkinson's disease dominates
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.Genes, trials, and care: the dynamics of neuromuscular disease
Lancet Neurology,volume 3,issue 1 , Vol. 3, Iss. 1, 2004-01 , pp.
Previous
Next